Know Cancer

or
forgot password

High Resolution MRI in the Evaluation of Laryngeal Neoplasia


N/A
18 Years
N/A
Not Enrolling
Both
Laryngeal Neoplasms, Head and Neck Cancers, Larynx Cancer

Thank you

Trial Information

High Resolution MRI in the Evaluation of Laryngeal Neoplasia


Inclusion Criteria:



- Patients with benign or malignant neoplasm of the larynx.

- Patients who have undergone prior surgery, radiation therapy, or chemotherapy for
cancer of the laryngopharynx will be eligible to participate.

- Patients 18 years of age and older at time of evaluation, male and female, all
ethnicities.

- Ability to understand and the willingness to sign a written informed consent
document.

Exclusion Criteria:

- Pregnancy

- Claustrophobia.

- Anatomic parameters which preclude scanning, such as limited range of neck motion, or
inability to remain flat for at least 15 minutes.

- Patients with implanted devices (eg, defibrillator, pacemaker) that are a known
contraindication to magnetic resonance imaging.

- Allergy to gadolinium contrast.

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Tumor stage as determined by histopathology in excised larynges.

Outcome Time Frame:

4 to 6 weeks

Safety Issue:

No

Principal Investigator

Edward J. Damrose MD, FACS

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

ENT0019

NCT ID:

NCT00965003

Start Date:

July 2009

Completion Date:

July 2014

Related Keywords:

  • Laryngeal Neoplasms
  • Head and Neck Cancers
  • Larynx Cancer
  • Neoplasms
  • Laryngeal Neoplasms
  • Head and Neck Neoplasms
  • Laryngeal Diseases

Name

Location

Stanford University School of MedicineStanford, California  94305-5317